Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:5 Issue:3 Number:57 ISSN#:2564-2537
RCT
ACE Report #8697
Ace Report Cover Arthroplasty

AAOS 2016: Intraarticular & intravenous tranexamic acid similar for blood loss in THA


How to Cite

OrthoEvidence. AAOS 2016: Intraarticular & intravenous tranexamic acid similar for blood loss in THA. ACE Report. 2016;5(3):57. Available from: https://myorthoevidence.com/AceReport/Report/8697

Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Topical Compared to Intravenous Tranexamic Acid in Total Hip Arthroplasty - A Prospective Randomized Trial

Contributing Authors: S Ghijselings B Jacobs R Driesen K Corten

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

120 patients undergoing total hip arthroplasty (THA) were randomized to receive either 3g intra-articular tranexamic acid or 1.5g intravenous tranexamic acid. The purpose of this study was to compare these methods of administration in terms of their effects on postoperative blood loss, length of hospital stay, and transfusion rate in THA patients. There were no significant differences between grou...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.